Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 3 4Phase 2 3Phase 4 1Phase 1 1

Status

Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 44NIH 9NETWORK 7INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Lung Neoplasms 1Carcinoma 1Adenocarcinoma 1

Interventions

Carboplatin 272Paclitaxel 267Gemcitabine 244Bevacizumab 225Cisplatin 216pembrolizumab 213Docetaxel 210Pemetrexed 162Capecitabine 148Fluorouracil 129Oxaliplatin 121Cyclophosphamide 121Nivolumab 112Dexamethasone 99Trastuzumab 89Leucovorin 87Cetuximab 85Rituximab 83Irinotecan 82Injections 80Erlotinib Hydrochloride 70Prednisone 68Doxorubicin 68Temozolomide 67atezolizumab 65Ipilimumab 64Bortezomib 64Fulvestrant 59Radiotherapy 54Drug Therapy 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × INDUSTRY × Brachytherapy × Clear all
NCT03290534 2025-04-04

Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®

CivaTech Oncology

Phase 2 Recruiting
40 enrolled
Thoracic

Lung Neoplasms

NCT01374087 2019-09-18

ANABRAQ

Ipsen

Phase 2 Terminated
32 enrolled 9 charts
Genitourinary

Prostatic Neoplasms

NCT01301612 2014-07-14

Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)

Eurofarma Laboratorios S.A.

Phase 2 Withdrawn
Tumor-Agnostic

Adenocarcinoma, Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡